| Year |
Citation |
Score |
| 2024 |
Dieussaert I, Hyung Kim J, Luik S, Seidl C, Pu W, Stegmann JU, Swamy GK, Webster P, Dormitzer PR. RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes. The New England Journal of Medicine. 390: 1009-1021. PMID 38477988 DOI: 10.1056/NEJMoa2305478 |
0.372 |
|
| 2023 |
Che Y, Gribenko AV, Song X, Handke LD, Efferen KS, Tompkins K, Kodali S, Nunez L, Prasad AK, Phelan LM, Ammirati M, Yu X, Lees JA, Chen W, Martinez L, ... ... Dormitzer PR, et al. Rational Design of a Highly Immunogenic Prefusion-Stabilized F Glycoprotein Antigen for a Respiratory Syncytial Virus Vaccine. Science Translational Medicine. eade6422. PMID 37023209 DOI: 10.1126/scitranslmed.ade6422 |
0.404 |
|
| 2022 |
Tabata T, Petitt M, Li J, Chi X, Chen W, Yurgelonis I, Wellnitz S, Bredl S, Vicente T, Yang X, Dormitzer PR, Pereira L. Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas. Vaccines. 10. PMID 35891239 DOI: 10.3390/vaccines10071074 |
0.333 |
|
| 2022 |
Schmoele-Thoma B, Zareba AM, Jiang Q, Maddur MS, Danaf R, Mann A, Eze K, Fok-Seang J, Kabir G, Catchpole A, Scott DA, Gurtman AC, Jansen KU, Gruber WC, Dormitzer PR, et al. Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. The New England Journal of Medicine. 386: 2377-2386. PMID 35731653 DOI: 10.1056/NEJMoa2116154 |
0.395 |
|
| 2022 |
Baber J, Arya M, Moodley Y, Jaques A, Jiang Q, Swanson KA, Cooper D, Maddur MS, Loschko J, Gurtman A, Jansen KU, Gruber WC, Dormitzer PR, Schmoele-Thoma B. A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults. The Journal of Infectious Diseases. PMID 35543281 DOI: 10.1093/infdis/jiac189 |
0.325 |
|
| 2022 |
Simões EAF, Center KJ, Tita ATN, Swanson KA, Radley D, Houghton J, McGrory SB, Gomme E, Anderson M, Roberts JP, Scott DA, Jansen KU, Gruber WC, Dormitzer PR, Gurtman AC. Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy. The New England Journal of Medicine. 386: 1615-1626. PMID 35476650 DOI: 10.1056/NEJMoa2106062 |
0.352 |
|
| 2022 |
Li J, Wellnitz S, Chi XS, Yue Y, Schmidt KA, Nguyen N, Chen W, Yurgelonis I, Rojas E, Liu Y, Loschko J, Pollozi E, Matsuka YV, Needle E, Vidunas E, ... ... Dormitzer PR, et al. Horizontal transmission of cytomegalovirus in a rhesus model despite high-level, vaccine-elicited neutralizing antibody and T cell responses. The Journal of Infectious Diseases. PMID 35413121 DOI: 10.1093/infdis/jiac129 |
0.386 |
|
| 2022 |
Liu J, Liu Y, Xia H, Zou J, Weaver SC, Swanson KA, Cai H, Cutler M, Cooper D, Muik A, Jansen KU, Sahin U, Xie X, Dormitzer PR, Shi PY. BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants. Npj Vaccines. 7: 41. PMID 35396516 DOI: 10.1038/s41541-022-00462-4 |
0.305 |
|
| 2022 |
Moreira ED, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, Perez JL, Zerbini C, Dever ME, Jennings TW, Brandon DM, Cannon KD, Koren MJ, Denham DS, Berhe M, ... ... Dormitzer PR, et al. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine. The New England Journal of Medicine. PMID 35320659 DOI: 10.1056/NEJMoa2200674 |
0.335 |
|
| 2021 |
Walsh EE, Falsey AR, Scott DA, Gurtman A, Zareba AM, Jansen KU, Gruber WC, Dormitzer PR, Swanson KA, Radley D, Gomme E, Cooper D, Schmoele-Thoma B. A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine. The Journal of Infectious Diseases. PMID 34932102 DOI: 10.1093/infdis/jiab612 |
0.403 |
|
| 2021 |
Falsey AR, Walsh EE, Scott DA, Gurtman A, Zareba A, Jansen KU, Gruber WC, Dormitzer PR, Swanson KA, Jiang Q, Gomme E, Cooper D, Schmoele-Thoma B. Phase 1/2 Randomized Study of the Immunogenicity, Safety and Tolerability of an RSV Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine. The Journal of Infectious Diseases. PMID 34931667 DOI: 10.1093/infdis/jiab611 |
0.367 |
|
| 2021 |
Peterson JT, Zareba AM, Fitz-Patrick D, Essink BJ, Scott DA, Swanson KA, Chelani D, Radley D, Cooper D, Jansen KU, Dormitzer PR, Gruber WC, Gurtman A. Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Co-Administered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine. The Journal of Infectious Diseases. PMID 34637519 DOI: 10.1093/infdis/jiab505 |
0.433 |
|
| 2021 |
Thomas SJ, Moreira ED, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Polack FP, Zerbini C, Bailey R, Swanson KA, Xu X, Roychoudhury S, Koury K, ... ... Dormitzer PR, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. The New England Journal of Medicine. PMID 34525277 DOI: 10.1056/NEJMoa2110345 |
0.368 |
|
| 2021 |
Falsey AR, Frenck RW, Walsh EE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Bailey R, Swanson KA, Xu X, Koury K, Kalina W, Cooper D, Zou J, Xie X, ... ... Dormitzer PR, et al. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3. The New England Journal of Medicine. PMID 34525276 DOI: 10.1056/NEJMc2113468 |
0.355 |
|
| 2021 |
Penkert RR, Chandramouli S, Dormitzer PR, Settembre EC, Sealy RE, Wong S, Young NS, Sun Y, Tang L, Cotton A, Dowdy J, Hayden RT, Hankins JS, Hurwitz JL. Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines. 9. PMID 34451986 DOI: 10.3390/vaccines9080860 |
0.407 |
|
| 2021 |
Liu J, Liu Y, Xia H, Zou J, Weaver SC, Swanson KA, Cai H, Cutler M, Cooper D, Muik A, Jansen KU, Sahin U, Xie X, Dormitzer PR, Shi PY. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Nature. PMID 34111888 DOI: 10.1038/s41586-021-03693-y |
0.36 |
|
| 2021 |
Frenck RW, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S, Bailey R, Swanson KA, Ma H, Xu X, Koury K, Kalina WV, ... ... Dormitzer PR, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. The New England Journal of Medicine. PMID 34043894 DOI: 10.1056/NEJMoa2107456 |
0.344 |
|
| 2021 |
Zou J, Xie X, Fontes-Garfias CR, Swanson KA, Kanevsky I, Tompkins K, Cutler M, Cooper D, Dormitzer PR, Shi PY. The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization. Npj Vaccines. 6: 44. PMID 33767200 DOI: 10.1038/s41541-021-00313-8 |
0.445 |
|
| 2021 |
Liu Y, Heim KP, Che Y, Chi X, Qiu X, Han S, Dormitzer PR, Yang X. Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion. Science Advances. 7. PMID 33674318 DOI: 10.1126/sciadv.abf3178 |
0.327 |
|
| 2021 |
Xie X, Liu Y, Liu J, Zhang X, Zou J, Fontes-Garfias CR, Xia H, Swanson KA, Cutler M, Cooper D, Menachery VD, Weaver SC, Dormitzer PR, Shi PY. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature Medicine. PMID 33558724 DOI: 10.1038/s41591-021-01270-4 |
0.385 |
|
| 2021 |
Xie X, Liu Y, Liu J, Zhang X, Zou J, Fontes-Garfias CR, Xia H, Swanson KA, Cutler M, Cooper D, Menachery VD, Weaver S, Dormitzer PR, Shi PY. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera. Biorxiv : the Preprint Server For Biology. PMID 33532771 DOI: 10.1101/2021.01.27.427998 |
0.393 |
|
| 2021 |
Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, Kranz LM, Walzer KC, Hein S, Güler A, Loschko J, Maddur MS, Ota-Setlik A, Tompkins K, Cole J, ... ... Dormitzer PR, et al. Immunogenic BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. PMID 33524990 DOI: 10.1038/s41586-021-03275-y |
0.421 |
|
| 2021 |
Muik A, Wallisch AK, Sänger B, Swanson KA, Mühl J, Chen W, Cai H, Maurus D, Sarkar R, Türeci Ö, Dormitzer PR, Şahin U. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science (New York, N.Y.). PMID 33514629 DOI: 10.1126/science.abg6105 |
0.37 |
|
| 2021 |
Shi PY, Xie X, Zou J, Fontes-Garfias C, Xia H, Swanson K, Cutler M, Cooper D, Menachery V, Weaver S, Dormitzer P. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. Research Square. PMID 33469576 DOI: 10.21203/rs.3.rs-143532/v1 |
0.385 |
|
| 2021 |
Xie X, Zou J, Fontes-Garfias CR, Xia H, Swanson KA, Cutler M, Cooper D, Menachery VD, Weaver S, Dormitzer PR, Shi PY. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. Biorxiv : the Preprint Server For Biology. PMID 33442691 DOI: 10.1101/2021.01.07.425740 |
0.369 |
|
| 2020 |
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, ... ... Dormitzer PR, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. The New England Journal of Medicine. PMID 33301246 DOI: 10.1056/NEJMoa2034577 |
0.354 |
|
| 2020 |
Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, ... ... Dormitzer PR, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England Journal of Medicine. PMID 33053279 DOI: 10.1056/NEJMoa2027906 |
0.377 |
|
| 2020 |
Walsh EE, Frenck R, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, ... ... Dormitzer PR, et al. RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study. Medrxiv : the Preprint Server For Health Sciences. PMID 32839784 DOI: 10.1101/2020.08.17.20176651 |
0.377 |
|
| 2020 |
Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, ... ... Dormitzer PR, et al. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. PMID 32785213 DOI: 10.1038/s41586-020-2639-4 |
0.34 |
|
| 2020 |
Plotkin SA, Wang D, Oualim A, Diamond DJ, Kotton CN, Mossman S, Carfi A, Anderson D, Dormitzer PR. The Status of Vaccine Development Against the Human Cytomegalovirus. The Journal of Infectious Diseases. 221: S113-S122. PMID 32134478 DOI: 10.1093/Infdis/Jiz447 |
0.372 |
|
| 2018 |
Ferdman J, Palladino G, Liao HX, Moody MA, Kepler TB, Del Giudice G, Dormitzer PR, Harrison SC, Settembre EC, Suphaphiphat P. Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine. Vaccine. PMID 30055967 DOI: 10.1016/J.Vaccine.2018.06.054 |
0.498 |
|
| 2017 |
Penkert RR, Young NS, Surman SL, Sealy RE, Rosch J, Dormitzer PR, Settembre EC, Chandramouli S, Wong S, Hankins JS, Hurwitz JL. Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease. Vaccine. PMID 28554503 DOI: 10.1016/J.Vaccine.2017.05.022 |
0.512 |
|
| 2016 |
Raymond DD, Stewart SM, Lee J, Ferdman J, Bajic G, Do KT, Ernandes MJ, Suphaphiphat P, Settembre EC, Dormitzer PR, Del Giudice G, Finco O, Kang TH, Ippolito GC, Georgiou G, et al. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain. Nature Medicine. PMID 27820604 DOI: 10.1038/Nm.4223 |
0.554 |
|
| 2016 |
Suphaphiphat P, Whittaker L, De Souza I, Daniels RS, Dormitzer PR, McCauley JW, Settembre EC. Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones. Vaccine. PMID 27219338 DOI: 10.1016/J.Vaccine.2016.05.031 |
0.56 |
|
| 2016 |
Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings. Vaccine. PMID 27154389 DOI: 10.1016/J.Vaccine.2016.04.091 |
0.421 |
|
| 2015 |
Wen Y, Han L, Palladino G, Ferrari A, Xie Y, Carfi A, Dormitzer PR, Settembre EC. Conformationally selective biophysical assay for influenza vaccine potency determination. Vaccine. 33: 5342-9. PMID 26348403 DOI: 10.1016/J.Vaccine.2015.08.077 |
0.53 |
|
| 2015 |
Brito LA, Kommareddy S, Maione D, Uematsu Y, Giovani C, Berlanda Scorza F, Otten GR, Yu D, Mandl CW, Mason PW, Dormitzer PR, Ulmer JB, Geall AJ. Self-amplifying mRNA vaccines. Advances in Genetics. 89: 179-233. PMID 25620012 DOI: 10.1016/Bs.Adgen.2014.10.005 |
0.478 |
|
| 2014 |
Beigi RH, Fortner KB, Munoz FM, Roberts J, Gordon JL, Han HH, Glenn G, Dormitzer PR, Gu XX, Read JS, Edwards K, Patel SM, Swamy GK. Maternal immunization: opportunities for scientific advancement. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: S408-14. PMID 25425719 DOI: 10.1093/Cid/Ciu708 |
0.415 |
|
| 2014 |
Swanson KA, Balabanis K, Xie Y, Aggarwal Y, Palomo C, Mas V, Metrick C, Yang H, Shaw CA, Melero JA, Dormitzer PR, Carfi A. A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes. Journal of Virology. 88: 11802-10. PMID 25078705 DOI: 10.1128/Jvi.01225-14 |
0.44 |
|
| 2014 |
Brito LA, Chan M, Shaw CA, Hekele A, Carsillo T, Schaefer M, Archer J, Seubert A, Otten GR, Beard CW, Dey AK, Lilja A, Valiante NM, Mason PW, Mandl CW, ... ... Dormitzer PR, et al. A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 2118-29. PMID 25027661 DOI: 10.1038/Mt.2014.133 |
0.461 |
|
| 2014 |
Dormitzer PR. Rapid production of synthetic influenza vaccines. Current Topics in Microbiology and Immunology. 386: 237-273. PMID 24996863 DOI: 10.1007/82_2014_399 |
0.545 |
|
| 2014 |
Bart SA, Hohenboken M, Cioppa GD, Narasimhan V, Dormitzer PR, Kanesa-thasan N. A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults Science Translational Medicine. 6. PMID 24786323 DOI: 10.1126/Scitranslmed.3008761 |
0.548 |
|
| 2014 |
Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL. Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model. Vaccine. 32: 3264-73. PMID 24721531 DOI: 10.1016/J.Vaccine.2014.03.088 |
0.533 |
|
| 2014 |
Settembre EC, Dormitzer PR, Rappuoli R. Bringing influenza vaccines into the 21st century. Human Vaccines & Immunotherapeutics. 10: 600-4. PMID 24378716 DOI: 10.4161/Hv.27600 |
0.528 |
|
| 2013 |
Hekele A, Bertholet S, Archer J, Gibson DG, Palladino G, Brito LA, Otten GR, Brazzoli M, Buccato S, Bonci A, Casini D, Maione D, Qi ZQ, Gill JE, Caiazza NC, ... ... Dormitzer PR, et al. Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice. Emerging Microbes & Infections. 2: e52. PMID 26038486 DOI: 10.1038/Emi.2013.54 |
0.542 |
|
| 2013 |
Gomila RC, Suphaphiphat P, Judge C, Spencer T, Ferrari A, Wen Y, Palladino G, Dormitzer PR, Mason PW. Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments. Vaccine. 31: 4736-43. PMID 23973324 DOI: 10.1016/J.Vaccine.2013.08.026 |
0.432 |
|
| 2013 |
Chandramouli S, Medina-Selby A, Coit D, Schaefer M, Spencer T, Brito LA, Zhang P, Otten G, Mandl CW, Mason PW, Dormitzer PR, Settembre EC. Generation of a parvovirus B19 vaccine candidate. Vaccine. 31: 3872-8. PMID 23827313 DOI: 10.1016/J.Vaccine.2013.06.062 |
0.482 |
|
| 2013 |
Shaw CA, Ciarlet M, Cooper BW, Dionigi L, Keith P, O'Brien KB, Rafie-Kolpin M, Dormitzer PR. The path to an RSV vaccine. Current Opinion in Virology. 3: 332-42. PMID 23727193 DOI: 10.1016/J.Coviro.2013.05.003 |
0.496 |
|
| 2013 |
Dormitzer PR, Suphaphiphat P, Gibson DG, Wentworth DE, Stockwell TB, Algire MA, Alperovich N, Barro M, Brown DM, Craig S, Dattilo BM, Denisova EA, De Souza I, Eickmann M, Dugan VG, et al. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Science Translational Medicine. 5: 185ra68. PMID 23677594 DOI: 10.1126/Scitranslmed.3006368 |
0.547 |
|
| 2013 |
Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 31: B209-15. PMID 23598484 DOI: 10.1016/J.Vaccine.2012.11.106 |
0.524 |
|
| 2013 |
Kommareddy S, Baudner BC, Bonificio A, Gallorini S, Palladino G, Determan AS, Dohmeier DM, Kroells KD, Sternjohn JR, Singh M, Dormitzer PR, Hansen KJ, O'Hagan DT. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine. 31: 3435-41. PMID 23398932 DOI: 10.1016/J.Vaccine.2013.01.050 |
0.485 |
|
| 2013 |
Schmidt AG, Xu H, Khan AR, O'Donnell T, Khurana S, King LR, Manischewitz J, Golding H, Suphaphiphat P, Carfi A, Settembre EC, Dormitzer PR, Kepler TB, Zhang R, Moody MA, et al. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proceedings of the National Academy of Sciences of the United States of America. 110: 264-9. PMID 23175789 DOI: 10.1073/Pnas.1218256109 |
0.505 |
|
| 2013 |
Shaw CA, Galarneau JR, Bowenkamp KE, Swanson KA, Palmer GA, Palladino G, Markovits JE, Valiante NM, Dormitzer PR, Otten GR. The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease. Vaccine. 31: 306-12. PMID 23153444 DOI: 10.1016/J.Vaccine.2012.11.006 |
0.504 |
|
| 2012 |
Dormitzer PR, Grandi G, Rappuoli R. Structural vaccinology starts to deliver Nature Reviews Microbiology. 10: 807-813. PMID 23154260 DOI: 10.1038/Nrmicro2893 |
0.353 |
|
| 2012 |
Geall AJ, Verma A, Otten GR, Shaw CA, Hekele A, Banerjee K, Cu Y, Beard CW, Brito LA, Krucker T, O'Hagan DT, Singh M, Mason PW, Valiante NM, Dormitzer PR, et al. Nonviral delivery of self-amplifying RNA vaccines. Proceedings of the National Academy of Sciences of the United States of America. 109: 14604-9. PMID 22908294 DOI: 10.1073/Pnas.1209367109 |
0.427 |
|
| 2012 |
Cooper BW, Dormitzer PR, Ciarlet M. The epidemiology of respiratory syncytial virus lower respiratory tract infection on young children. Pediatric Infectious Disease Journal. 31: 883. PMID 22801098 DOI: 10.1097/Inf.0B013E31825C11B6 |
0.303 |
|
| 2012 |
Rappuoli R, Dormitzer PR. Influenza: Options to Improve Pandemic Preparation Science. 336: 1531-1533. PMID 22723412 DOI: 10.1126/Science.1221466 |
0.357 |
|
| 2012 |
Dormitzer PR, Tsai TF, Giudice GD. New technologies for influenza vaccines Human Vaccines & Immunotherapeutics. 8: 45-58. PMID 22251994 DOI: 10.4161/Hv.8.1.18859 |
0.52 |
|
| 2011 |
Aoki ST, Trask SD, Coulson BS, Greenberg HB, Dormitzer PR, Harrison SC. Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. Journal of Virology. 85: 10509-17. PMID 21849465 DOI: 10.1128/Jvi.00234-11 |
0.388 |
|
| 2011 |
Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, Dormitzer PR, Haynes BF, Walter EB, Moody MA, Kepler TB, Liao HX, Harrison SC. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proceedings of the National Academy of Sciences of the United States of America. 108: 14216-21. PMID 21825125 DOI: 10.1073/pnas.1111497108 |
0.413 |
|
| 2011 |
Swanson KA, Settembre EC, Shaw CA, Dey AK, Rappuoli R, Mandl CW, Dormitzer PR, Carfi A. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proceedings of the National Academy of Sciences of the United States of America. 108: 9619-24. PMID 21586636 DOI: 10.1073/Pnas.1106536108 |
0.438 |
|
| 2011 |
Settembre EC, Dormitzer PR, Rappuoli R. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines. Journal of Molecular Cell Biology. 3: 144-6. PMID 21430014 DOI: 10.1093/Jmcb/Mjq046 |
0.531 |
|
| 2011 |
Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, Del Giudice G, Rappuoli R. Influenza vaccine immunology. Immunological Reviews. 239: 167-77. PMID 21198671 DOI: 10.1111/J.1600-065X.2010.00974.X |
0.543 |
|
| 2011 |
Settembre EC, Chen JZ, Dormitzer PR, Grigorieff N, Harrison SC. Atomic model of an infectious rotavirus particle. The Embo Journal. 30: 408-16. PMID 21157433 DOI: 10.1038/Emboj.2010.322 |
0.382 |
|
| 2010 |
Bucher D, Tumpey T, Lowen A, Gill J, Shaw M, Matthews J, Galarza J, Arroyo JM, Dormitzer PR. 2009 H1N1 swine flu: the 2010 perspective. Annals of the New York Academy of Sciences. E10-20. PMID 20860673 DOI: 10.1111/J.1749-6632.2010.05739.X |
0.374 |
|
| 2010 |
Suphaphiphat P, Franti M, Hekele A, Lilja A, Spencer T, Settembre E, Palmer G, Crotta S, Tuccino AB, Keiner B, Trusheim H, Balabanis K, Sackal M, Rothfeder M, Mandl CW, ... Dormitzer PR, et al. Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs. Virology Journal. 7: 157. PMID 20630098 DOI: 10.1186/1743-422X-7-157 |
0.515 |
|
| 2010 |
Kim IS, Trask SD, Babyonyshev M, Dormitzer PR, Harrison SC. Effect of mutations in VP5 hydrophobic loops on rotavirus cell entry. Journal of Virology. 84: 6200-7. PMID 20375171 DOI: 10.1128/Jvi.02461-09 |
0.339 |
|
| 2010 |
Settembre EC, Dormitzer PR, Rappuoli R. H1N1: can a pandemic cycle be broken? Science Translational Medicine. 2: 24ps14. PMID 20375006 DOI: 10.1126/Scitranslmed.3000948 |
0.435 |
|
| 2010 |
Rappuoli R, Medini D, Siena E, Budroni S, Dormitzer PR, Del Giudice G. Building an insurance against modern pandemics. Current Opinion in Investigational Drugs (London, England : 2000). 11: 126-30. PMID 20112161 |
0.376 |
|
| 2010 |
Suphaphiphat P, Keiner B, Trusheim H, Crotta S, Tuccino AB, Zhang P, Dormitzer PR, Mason PW, Franti M. Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells. Journal of Virology. 84: 3721-5. PMID 20071567 DOI: 10.1128/Jvi.01925-09 |
0.459 |
|
| 2010 |
Trask SD, Kim IS, Harrison SC, Dormitzer PR. A rotavirus spike protein conformational intermediate binds lipid bilayers. Journal of Virology. 84: 1764-70. PMID 20007281 DOI: 10.1128/Jvi.01682-09 |
0.376 |
|
| 2009 |
Dormitzer PR, Rappuoli R, Casini D, O'Hagan D, Runham C, Montomoli E, Baudner B, Donnelly Iii JJ, Lapini G, Wack A. Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice. Plos Currents. 1: RRN1025. PMID 20029611 DOI: 10.1371/currents.RRN1025 |
0.458 |
|
| 2009 |
Yoder JD, Trask SD, Vo TP, Binka M, Feng N, Harrison SC, Greenberg HB, Dormitzer PR. VP5* rearranges when rotavirus uncoats. Journal of Virology. 83: 11372-7. PMID 19692464 DOI: 10.1128/Jvi.01228-09 |
0.396 |
|
| 2009 |
Shaw CA, Otten G, Wack A, Palmer GA, Mandl CW, Mbow ML, Valiante N, Dormitzer PR. Antibody affinity maturation and respiratory syncytial virus disease. Nature Medicine. 15: 725; author reply 72. PMID 19584854 DOI: 10.1038/Nm0709-725A |
0.377 |
|
| 2009 |
Aoki ST, Settembre EC, Trask SD, Greenberg HB, Harrison SC, Dormitzer PR. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science (New York, N.Y.). 324: 1444-7. PMID 19520960 DOI: 10.1126/Science.1170481 |
0.365 |
|
| 2009 |
Chen JZ, Settembre EC, Aoki ST, Zhang X, Bellamy AR, Dormitzer PR, Harrison SC, Grigorieff N. Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM. Proceedings of the National Academy of Sciences of the United States of America. 106: 10644-8. PMID 19487668 DOI: 10.1073/Pnas.0904024106 |
0.326 |
|
| 2009 |
Chen JZ, Settembre E, Aoki S, Dormitzer P, Bellamy R, Harrison S, Grigorieff N. High-Resolution Electron Microscopy of a Rotavirus Particle Biophysical Journal. 96: 413a. DOI: 10.1016/J.Bpj.2008.12.2110 |
0.336 |
|
| 2008 |
Dormitzer PR, Ulmer JB, Rappuoli R. Structure-based antigen design: a strategy for next generation vaccines. Trends in Biotechnology. 26: 659-667. PMID 18977045 DOI: 10.1016/J.Tibtech.2008.08.002 |
0.484 |
|
| 2006 |
Trask SD, Dormitzer PR. Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. Journal of Virology. 80: 11293-304. PMID 16971442 DOI: 10.1128/Jvi.01346-06 |
0.353 |
|
| 2006 |
Yoder JD, Dormitzer PR. Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement. The Embo Journal. 25: 1559-68. PMID 16511559 DOI: 10.1038/Sj.Emboj.7601034 |
0.421 |
|
| 2006 |
Monnier N, Higo-Moriguchi K, Sun ZY, Prasad BV, Taniguchi K, Dormitzer PR. High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. Journal of Virology. 80: 1513-23. PMID 16415027 DOI: 10.1128/Jvi.80.3.1513-1523.2006 |
0.329 |
|
| 2004 |
Dormitzer PR, Nason EB, Prasad BV, Harrison SC. Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature. 430: 1053-8. PMID 15329727 DOI: 10.1038/Nature02836 |
0.372 |
|
| 2002 |
Dormitzer PR, Sun ZY, Wagner G, Harrison SC. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. The Embo Journal. 21: 885-97. PMID 11867517 DOI: 10.1093/Emboj/21.5.885 |
0.341 |
|
| 2001 |
Dormitzer PR, Greenberg HB, Harrison SC. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core Journal of Virology. 75: 7339-7350. PMID 11462006 DOI: 10.1128/Jvi.75.16.7339-7350.2001 |
0.39 |
|
| 2000 |
Dormitzer PR, Greenberg HB, Harrison SC. Purified recombinant rotavirus VP7 forms soluble, calcium-dependent trimers Virology. 277: 420-428. PMID 11080489 DOI: 10.1006/Viro.2000.0625 |
0.363 |
|
| Show low-probability matches. |